Avidity Biosciences, Inc. 3 SEC Filings

Filed On	Filing
08 Jan 2025	Form 3: Mosbrooker Eric, Chief Commercial Officer Holds 36,120 shares of Common Stock
08 Jan 2025	Form 3: Gallagher Kathleen P., Chief Program Officer Holds 34,965 shares of Common Stock
08 Jan 2025	Form 3: Hughes Steven George, Chief Medical Officer Holds 61,375 shares of Common Stock
08 Jan 2025	Form 3: Calderaro Charles Iii, Chief Technical Officer No securities owned
05 Aug 2024	Form 3: Moriarty John B, Chief Legal Officer No securities owned
16 May 2024	Form 3: Skerjanec Simona, Director No securities owned
27 Aug 2021	Form 3: Mosbrooker Eric, Director No securities owned
20 May 2021	Form 3: McCarthy Teresa, Chief Human Resources Officer
25 Jan 2021	Form 3: Flanagan W. Michael, Chief Technical Officer No securities owned
11 Jan 2021	Form 3: Kim Jean Jinsun, Director No securities owned
11 Jan 2021	Form 3: Thompson Tamar, Director No securities owned
27 Jul 2020	Form 3: Kim Jae B., Chief Medical Officer No securities owned
11 Jun 2020	Form 3: Wilson Troy Edward, Director Holds 189,618 shares of Common Stock
11 Jun 2020	Form 3: Rtw INVESTMENTS, Lp, 10% owner and 1 other
11 Jun 2020	Form 3: Cormorant Asset Management, Lp, 10% owner and 3 others
11 Jun 2020	Form 3: Martin Michael B., Director No securities owned
11 Jun 2020	Form 3: Alexandria Venture Investments, Llc, 10% owner
11 Jun 2020	Form 3: Eli Lilly & Co, 10% owner
11 Jun 2020	Form 3: MacLean Michael F, Chief Financial Officer
11 Jun 2020	Form 3: Levin Arthur A, Chief Scientific Officer Holds 294,143 shares of Common Stock

Comments